Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL (CROSBI ID 536636)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Aurer, Igor ; Mitrović, Zdravko ; Nemet, Damir ; Radman, Ivo ; Setrtić, Dubravka ; Serventi Seiwerth, Ranka ; Štern Padovan, Ranka ; Šantek, Fedor ; Nola, Marin ; Mrsić, Mirando ; Labar, Boris.
engleski
Changing from a first to second generation of ifosfamide.based regimen (from IMVP to ICE) does not improve outcome of patients with relapsed or refractory aggressive NHL
Changing from the first generation ifosfamide based regimen , such as IMVP, to a second generation regimen, such as ICE, does not substantially improve outcomes of patients with relapsed or refractory aggressive NHL
Non-Hodgkin's lymphoma; ifosfamide-based regimens
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
360-x.
2007.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Haematologica
0390-6078
Podaci o skupu
12th Congress of the European Hematology Association
poster
07.06.2007-10.06.2007
Beč, Austrija
